1. Home
  2. ABBV vs WFC Comparison

ABBV vs WFC Comparison

Compare ABBV & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABBV
  • WFC
  • Stock Information
  • Founded
  • ABBV 2012
  • WFC 1852
  • Country
  • ABBV United States
  • WFC United States
  • Employees
  • ABBV N/A
  • WFC N/A
  • Industry
  • ABBV Biotechnology: Pharmaceutical Preparations
  • WFC Major Banks
  • Sector
  • ABBV Health Care
  • WFC Finance
  • Exchange
  • ABBV Nasdaq
  • WFC Nasdaq
  • Market Cap
  • ABBV 310.3B
  • WFC 249.8B
  • IPO Year
  • ABBV N/A
  • WFC N/A
  • Fundamental
  • Price
  • ABBV $171.54
  • WFC $77.09
  • Analyst Decision
  • ABBV Strong Buy
  • WFC Buy
  • Analyst Count
  • ABBV 22
  • WFC 21
  • Target Price
  • ABBV $207.25
  • WFC $72.52
  • AVG Volume (30 Days)
  • ABBV 5.7M
  • WFC 16.0M
  • Earning Date
  • ABBV 01-31-2025
  • WFC 01-15-2025
  • Dividend Yield
  • ABBV 3.82%
  • WFC 2.08%
  • EPS Growth
  • ABBV N/A
  • WFC 11.18
  • EPS
  • ABBV 2.87
  • WFC 5.37
  • Revenue
  • ABBV $55,533,000,000.00
  • WFC $77,962,000,000.00
  • Revenue This Year
  • ABBV $5.28
  • WFC N/A
  • Revenue Next Year
  • ABBV $5.79
  • WFC $4.49
  • P/E Ratio
  • ABBV $59.78
  • WFC $14.35
  • Revenue Growth
  • ABBV 0.72
  • WFC 0.99
  • 52 Week Low
  • ABBV $153.58
  • WFC $46.38
  • 52 Week High
  • ABBV $207.32
  • WFC $78.13
  • Technical
  • Relative Strength Index (RSI)
  • ABBV 40.01
  • WFC 69.70
  • Support Level
  • ABBV $168.72
  • WFC $69.34
  • Resistance Level
  • ABBV $177.98
  • WFC $76.82
  • Average True Range (ATR)
  • ABBV 3.06
  • WFC 1.50
  • MACD
  • ABBV -0.57
  • WFC 0.66
  • Stochastic Oscillator
  • ABBV 20.93
  • WFC 97.98

About ABBV AbbVie Inc.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

About WFC Wells Fargo & Company

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

Share on Social Networks: